Award

CA 116021

Funded outputs count: 24

Funder award ID: CA 116021

OpenAlex ID: G1188393146

Combined treatment with CDK4/6, CDK2, and CXCR1/2 inhibitors effectively halts the growth of BRAF wild-type melanoma tumors

2025 · Jinming Yang, Weifeng Luo, et al. · Frontiers in Oncology · 6

Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma

2023 · Chi Yan, Caroline Ann Nebhan, et al. · Cancers · 15

PDF

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

2022 · Vijaya Bharti, Reese Watkins, et al. · Cell Reports · 57

Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients

2022 · Chi Yan, Sheau-Chiann Chen, et al. · npj Precision Oncology · 10

PDF

Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy

2021 · Kennady Bullock, Ann Richmond · Cancers · 72

PDF

Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade

2021 · Chi Yan, Nabil Saleh, et al. · Molecular Cancer · 39

PDF

Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors

2021 · Roman V. Uzhachenko, Vijaya Bharti, et al. · Cell Reports · 101

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

2021 · Pataje G Prasanna, Deborah E Citrin, et al. · JNCI Journal of the National Cancer Institute · 353

PDF

Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies

2019 · Yu-Chuan Ou, Xiaona Wen, et al. · ACS Nano · 65

Combinatorial approach to cancer immunotherapy: strength in numbers

2016 · Anna E Vilgelm, Douglas B Johnson, et al. · Journal of Leukocyte Biology · 105

PDF

Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment

2015 · Anna E. Vilgelm, C. Andrew Johnson, et al. · JNCI Journal of the National Cancer Institute · 95

PDF

Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells

2014 · Anna E. Vilgelm, Jeff S. Pawlikowski, et al. · Cancer Research · 115

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

2014 · Kristen K. Ciombor, Yang Feng, et al. · Investigational New Drugs · 32

Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence

2012 · Yan Liu, Oriana E. Hawkins, et al. · EMBO Molecular Medicine · 101

PDF

Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma

2012 · Jinming Yang, Sara Kantrow, et al. · Cancer Research · 37

RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors

2012 · Yingjun Su, Anna E. Vilgelm, et al. · Clinical Cancer Research · 62

Chemokine research moves on

2011 · Ann Richmond · Experimental Cell Research · 11

Chemokines and chemokine receptors: new insights into cancer-related inflammation

2010 · Gwendal Lazennec, Ann Richmond · Trends in Molecular Medicine · 649

The good and the bad of chemokines/chemokine receptors in melanoma

2009 · Ann Richmond, Jinming Yang, et al. · Pigment Cell & Melanoma Research · 126

Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth

2007 · Jinming Yang, Wei-Hua Pan, et al. · Cancer Research · 52

CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells

2007 · Yukiko Ueda, Yingjun Su, et al. · Melanoma Research · 20

Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-κB pathway

2007 · Jinming Yang, Yingjun Su, et al. · Free Radical Biology and Medicine · 49

NF‐κB activation in melanoma

2006 · Yukiko Ueda, Ann Richmond · Pigment Cell Research · 163

BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways

2006 · Jinming Yang, Katayoun I. Amiri, et al. · Clinical Cancer Research · 167

PDF